BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BDHK-2009 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BDHK-2009\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07632573-82@assetmemo.bio
DTSTAMP:20261121T005623Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:BDHK-2009: Phase 1 readout est. (NCT07632573)
DESCRIPTION:BDHK-2009\, phase 1\, Ulcerative Colitis.\nStudy: A Phase I Stu
 dy to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adu
 lt\nEstimated primary completion: 31 December 2026. This is a ClinicalTria
 ls.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pa
 ge: https://assetmemo.bio/drug/bdhk-2009#upcoming-events\nRegistry record:
  https://clinicaltrials.gov/study/NCT07632573
URL:https://assetmemo.bio/drug/bdhk-2009#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
